openPR Logo
Press release

Oncolytic Virus Therapy Market Key Players (Genelux Corporation, Vyriad, TILT Biotherapeutics, Cold Genesys, etc...), Applications, Recent Developments in Healthcare, and Comprehensive Forecast to 2025

02-13-2018 12:07 PM CET | Health & Medicine

Press release from: ReportsWeb

Oncolytic Virus Therapy Market

Oncolytic Virus Therapy Market

ReportsWeb.com added “Global Oncolytic Virus Therapy Market Size, Status and Forecast 2025” to its vast collection of research Database. The report classifies the global Oncolytic Virus Therapy Market in a precise manner to offer detailed insights into the aspects responsible for augmenting as well as restraining market growth.

This comprehensive research report on the market for Oncolytic Virus Therapy market report provides a holistic overview of this market, taking its historical and current performance in consideration. It offers historical data and factual information of this market alongside the future projections in terms of both, volume as well as the value. And development policies and plans are discussed as well as manufacturing processes and cost structures.

This report studies the Oncolytic Virus Therapy market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions and splits the Oncolytic Virus Therapy market by product type and applications/end industries.

Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn't until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.

For developing a product, there are 3 products in Phase 3, 8 products in Phase 2, 7 products in Phase 1 and 3 products in Preclinical. The total investment for Oncolytic Virus Therapy developing is around 84 M USD in 2017.

Request for Sample @ http://www.reportsweb.com/inquiry&RW00011540870/sample

The major players in global Oncolytic Virus Therapy market include Amgen, Oncolytics Biotech, Viralytics, Transgene SA, Oncolys BioPharma, Targovax, PsiOxus Therapeutics, SillaJen Biotherapeutics, Sorrento Therapeutics, Lokon Pharma, Genelux Corporation, Vyriad, TILT Biotherapeutics, Cold Genesys, etc...

Geographically, this report is segmented into several key regions, with market size and R&D investment, market share and growth rate of Oncolytic Virus Therapy in these regions, from 2013 to 2025 forecast), covering
North America
Europe
Asia-Pacific

On the basis of the end users/applications, this report covers
Melanoma
Prostate Cancer
Breast Cancer
Ovarian Cancer
Others

Browse complete report @ http://www.reportsweb.com/global-oncolytic-virus-therapy-market-size-status-and-forecast-2025

Major points from Table of Contents:
1 Oncolytic Virus Therapy Market Overview 1
2 Global Oncolytic Virus Therapy Market Competition by Manufacturers 12
3 Global Oncolytic Virus Therapy R&D Investment by Regions 2013-2018) 21
4 Global Oncolytic Virus Therapy Market Size by Regions 2013-2018) 28
5 Global Oncolytic Virus Therapy R&D Investment by Application 33
6 Analysis of Oncolytic Virus Therapy Industry Key Manufacturers 36
6.1 Amgen 36
6.1.1 Company Profile 36
6.1.2 Product Information 37
6.1.3 R&D Investment, Product and Stage 37
6.2 Oncolytics Biotech 38
6.2.1 Company Profile 38
6.2.2 Product Information 39
6.2.3 R&D Investment, Product and Stage 39
6.3 Viralytics 40
6.3.1 Company Profile 40
6.3.2 Product Information 41
6.3.3 R&D Investment, Product and Stage 41
6.4 Transgene SA 42
6.4.1 Company Profile 42
6.4.2 Product Information 43
6.4.3 R&D Investment, Product and Stage 43
6.5 Oncolys BioPharma 44
6.5.1 Company Profile 44
6.5.2 Product Information 45
6.5.3 R&D Investment, Product and Stage 46
7 New Drugs Manufacturing Cost Analysis 68
8 Industrial Chain, Sourcing Strategy and Downstream Buyers 82
9 Marketing Strategy Analysis, Distributors/Traders 86
10 Market Effect Factors Analysis 92
11 Global Oncolytic Virus Therapy Market Forecast 2018-2025) 104
12 Research Findings and Conclusion 117

Place a DIRECT Purchase order for complete report @ http://www.reportsweb.com/buy&RW00011540870/buy/3300

ReportsWeb.com is a one stop shop for market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you with your research queries.

Contact Info:
Name: Sameer Joshi
Email: sales@reportsweb.com
Organization: ReportsWeb
Phone: +1-646-491-9876

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Oncolytic Virus Therapy Market Key Players (Genelux Corporation, Vyriad, TILT Biotherapeutics, Cold Genesys, etc...), Applications, Recent Developments in Healthcare, and Comprehensive Forecast to 2025 here

News-ID: 941436 • Views:

More Releases from ReportsWeb

North America: Smart Airport Market Overall Study Report 2020-2026| Amadeus IT Group S.A., Cisco, Honeywell, IBM, QinetiQ Group Plc, Sabre Corporation, Siemens ,Rockwell Collins Inc, Thales Group and T Systems International GmbH
North America: Smart Airport Market Overall Study Report 2020-2026| Amadeus IT G …
The "Global North America Smart Airport Market: 2020" Industry Report is a professional and in-depth study on the current state of the North America Smart Airport Market by PMR. The North America Smart Airport market is supposed to demonstrate a considerable growth during the forecast period of 2020 - 2026. The company profiles of all the key players and brands that are dominating the market have been given in this
Marine Biotechnology Market Future Forecast 2018-2026 by Leading Companies such as BASF, Abbott Laboratories, Lonza Group, Nofima, Aker Biomarine, Cyanotech Corporation, New England Biolabs, GlycoMar, Pharmamara, Nutrex Hawaii Incorporated, Marinova, Fmc
Marine Biotechnology Market Future Forecast 2018-2026 by Leading Companies such …
ReportsWeb.com has announced the addition of the “Marine Biotechnology-Global Market Outlook 2017-2026” The report classifies the global Marine Biotechnology Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. According to Publisher, the Global Marine Biotechnology Market is accounted for $3.93 billion in 2017 and is expected to reach $8.74 billion by 2026 growing at a CAGR of 9.3% during
Anti-Counterfeiting Packaging Market Growth Opportunities and Emerging Trends by Analysis of Key Vendors like Alien Technology, 3M Company, Acg Pharmapack, Advanced Track & Trace, AlpVision S.A., Angstrom Technologies, Atlantic Zeiser, TruTag Technologies
Anti-Counterfeiting Packaging Market Growth Opportunities and Emerging Trends by …
ReportsWeb.com has announced the addition of the “Anti-Counterfeiting Packaging-Global Market Outlook 2017-2026” The report classifies the global Anti-Counterfeiting Packaging Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. According to Publisher, the Global Anti-Counterfeiting Packaging Market is accounted for $112.16 billion in 2017 and is expected to reach $427.96 billion by 2026 growing at a CAGR of 16.0% during
Solar Photovoltaic in Italy Market Outlook to 2030 | Company Profiles (Tozzi Holding, Silver Ridge Power, RTR Capital, Mitsubishi Corporation, Etrion Corporation)
Solar Photovoltaic in Italy Market Outlook to 2030 | Company Profiles (Tozzi Hol …
Solar Photovoltaic (PV) in Italy, Market Outlook to 2030, Update 2018-Capacity, Generation, Investment Trends, Regulations and Company Profiles Summary "Solar Photovoltaic (PV) in Italy, Market Outlook to 2030, Update 2018-Capacity, Generation, Investment Trends, Regulations and Company Profiles", is the latest report from Publisher, the industry analysis specialists that offer comprehensive information and understanding of the Solar Photovoltaic (PV) market in Italy. The report provides in depth analysis on global renewable power market and

All 4 Releases


More Releases for Oncolytic

Oncolytic Virus Market: Know Applications Supporting Impressive Growth
A new business intelligence report released by HTF MI with title "Global Oncolytic Virus Market Professional Survey Report 2019" is designed covering micro level of analysis by manufacturers and key business segments. The Global Oncolytic Virus Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary statistics sources and it comprises both qualitative and quantitative
Oncolytic Virus Therapy Market Oncolytic Virus Therapy Clinical Pipeline Report …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Prologue to Oncolytic Virus 1.1 Outline of Oncolytic Virotherapy 1.2 Trail from Genesis to Biogenetics Primer of Virotherapy in Malignancies 2.1 Oncolytic Viruses towards Cancer 2.2 Approaches for Targeting Tumor Cells 2.2.1 Pro Apoptotic Targeting 2.2.2 Translational Targeting 2.2.3 Transcriptional Targeting 2.2.4 Transductional Targeting Mechanism
Global Oncolytic Virus Therapy Report Highlight Market Opportunity & Insight On …
“Global Oncolytic Virus Therapy Market and Pipeline Outlook 2022” report analyzes ongoing clinical and non-clinical trends in the oncolytic virus therapy market. Currently there are 2 oncolytic virus therapies commercially available in the market. This report analyzes the ongoing clinical trial of 48 oncolytic virus therapies in clinical pipeline and gives comprehensive clinical insight on various parameters associated with the development of the oncolytic virus therapies. Most of the oncolytic
Global Oncolytic Virus Therapy Market & Oncolytic Virus clinical Trials Outlook …
Advancements in human genomics over the last two decades have shown that cancer is mediated by somatic aberration in the host genome. This discovery has incited enthusiasm among cancer researchers; many now use therapeutic approaches in genetic manipulation to improve cancer regression and find a potential cure for the disease. The dominant cancer treatment modalities such as chemotherapy, radiotherapy, and even targeted kinase inhibitors and mAbs are limited by low
Global Oncolytic Virus Therapy Pipeline Analysis
Though still in nascent stages, Oncolytic viruses have shown immense opportunities and potential to be tapped in the future to improve the treatment of cancer and the lives of the patients. Immunotherapy, the umbrella for Oncolytic viruses would not offer cures, but survival solutions with significant importance. Also, the side effects of this therapy would be tolerable by the patients, which could thus become the most important approach to treat
Global Oncolytic Virus Therapy Market and Pipeline Outlook 2022
“Global Oncolytic Virus Therapy Market and Pipeline Outlook 2022” report analyzes ongoing clinical and non-clinical trends in the oncolytic virus therapy market. Currently there are 2 oncolytic virus therapies commercially available in the market. This report analyzes the ongoing clinical trial of 48 oncolytic virus therapies in clinical pipeline and gives comprehensive clinical insight on various parameters associated with the development of the oncolytic virus therapies. Most of the oncolytic